Plain-English translation of NCT06725953 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a 12-week remote exercise program designed specifically for cancer survivors who are experiencing memory and thinking difficulties—sometimes called 'chemo-brain'—after chemotherapy. The program uses smartphone apps and wearable fitness trackers to guide participants through personalized aerobic exercise and strength training, with built-in goal-setting and health education features. Researchers want to see if regular physical activity can reduce inflammation in the brain and improve both thinking and heart health in cancer survivors, especially those who also have type 2 diabetes.
Many cancer survivors report memory and cognitive problems after chemotherapy, which can hurt their quality of life. Research suggests chemotherapy may damage blood vessels in the brain and trigger inflammation that affects thinking and memory. This trial exists to find out whether a structured, accessible exercise program delivered at home can help reduce this inflammation and improve cognitive function—particularly for survivors who also manage type 2 diabetes, which shares similar harmful mechanisms.
You likely qualify if…
You likely don't qualify if…
Over 12 weeks, you would use two smartphone apps—one for tracking your fitness activity and one for accessing guided workouts and health education. You'll receive a Fitbit device to monitor your activity and resistance bands for strength training at home. The program is designed to be personalized to your fitness level and delivered entirely remotely, so you can participate from home on your own schedule. Researchers will measure changes in your thinking, memory, inflammation markers, and heart health before and after the program.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
United States